These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 20713893
21. Cytokine production by human odontoblast-like cells upon Toll-like receptor-2 engagement. Farges JC, Carrouel F, Keller JF, Baudouin C, Msika P, Bleicher F, Staquet MJ. Immunobiology; 2011 Apr; 216(4):513-7. PubMed ID: 20850890 [Abstract] [Full Text] [Related]
22. Impaired osteoclastogenesis by staphylococcal lipoteichoic acid through Toll-like receptor 2 with partial involvement of MyD88. Yang J, Ryu YH, Yun CH, Han SH. J Leukoc Biol; 2009 Oct; 86(4):823-31. PubMed ID: 19602669 [Abstract] [Full Text] [Related]
23. Propofol inhibits lipoteichoic acid-induced iNOS gene expression in macrophages possibly through downregulation of toll-like receptor 2-mediated activation of Raf-MEK1/2-ERK1/2-IKK-NFkappaB. Chiu WT, Lin YL, Chou CW, Chen RM. Chem Biol Interact; 2009 Oct 30; 181(3):430-9. PubMed ID: 19573522 [Abstract] [Full Text] [Related]
24. Lipoteichoic acid from Staphylococcus aureus increases matrix metalloproteinase 9 expression in RAW 264.7 macrophages: modulation by A2A and A2B adenosine receptors. Souza LF, Jardim FR, Sauter IP, Souza MM, Barreto F, Margis R, Bernard EA. Mol Immunol; 2009 Feb 30; 46(5):937-42. PubMed ID: 18950865 [Abstract] [Full Text] [Related]
25. Combined inhibition of complement and CD14 efficiently attenuated the inflammatory response induced by Staphylococcus aureus in a human whole blood model. Skjeflo EW, Christiansen D, Espevik T, Nielsen EW, Mollnes TE. J Immunol; 2014 Mar 15; 192(6):2857-64. PubMed ID: 24516199 [Abstract] [Full Text] [Related]
26. Impaired TLR-2 expression and TLR-2-mediated cytokine secretion in macrophages from patients with atopic dermatitis. Niebuhr M, Lutat C, Sigel S, Werfel T. Allergy; 2009 Nov 15; 64(11):1580-7. PubMed ID: 19392987 [Abstract] [Full Text] [Related]
27. Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36. Nilsen NJ, Deininger S, Nonstad U, Skjeldal F, Husebye H, Rodionov D, von Aulock S, Hartung T, Lien E, Bakke O, Espevik T. J Leukoc Biol; 2008 Jul 15; 84(1):280-91. PubMed ID: 18458151 [Abstract] [Full Text] [Related]
29. Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2. Han SH, Kim JH, Martin M, Michalek SM, Nahm MH. Infect Immun; 2003 Oct 15; 71(10):5541-8. PubMed ID: 14500472 [Abstract] [Full Text] [Related]
30. A food-born heterocyclic amine, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), suppresses tumor necrosis factor-alpha expression in lipoteichoic acid-stimulated RAW 264.7 cells. Im J, Choi HS, Kim SK, Woo SS, Ryu YH, Kang SS, Yun CH, Han SH. Cancer Lett; 2009 Feb 08; 274(1):109-17. PubMed ID: 18845389 [Abstract] [Full Text] [Related]
31. Highly purified lipoteichoic acid induced pro-inflammatory signalling in primary culture of rat microglia through Toll-like receptor 2: selective potentiation of nitric oxide production by muramyl dipeptide. Kinsner A, Boveri M, Hareng L, Brown GC, Coecke S, Hartung T, Bal-Price A. J Neurochem; 2006 Oct 08; 99(2):596-607. PubMed ID: 16879708 [Abstract] [Full Text] [Related]
32. Toll like receptor 2 agonists lipoteichoic acid and peptidoglycan are able to enhance antigen specific IFNγ release in whole blood during recall antigen responses. Dammermann W, Wollenberg L, Bentzien F, Lohse A, Lüth S. J Immunol Methods; 2013 Oct 31; 396(1-2):107-15. PubMed ID: 23954282 [Abstract] [Full Text] [Related]
33. Human monocytoid cells as a model to study Toll-like receptor-mediated activation. Remer KA, Brcic M, Sauter KS, Jungi TW. J Immunol Methods; 2006 Jun 30; 313(1-2):1-10. PubMed ID: 16720029 [Abstract] [Full Text] [Related]
34. Lipoproteins in Streptococcus gordonii are critical in the infection and inflammatory responses. Kim HY, Kim AR, Seo HS, Baik JE, Ahn KB, Yun CH, Han SH. Mol Immunol; 2018 Sep 30; 101():574-584. PubMed ID: 30176521 [Abstract] [Full Text] [Related]
35. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, Akashi S, Miyake K, Godowski PJ, Makino H. Arthritis Rheum; 2004 May 30; 50(5):1457-67. PubMed ID: 15146415 [Abstract] [Full Text] [Related]
36. Structural reevaluation of Streptococcus pneumoniae Lipoteichoic acid and new insights into its immunostimulatory potency. Gisch N, Kohler T, Ulmer AJ, Müthing J, Pribyl T, Fischer K, Lindner B, Hammerschmidt S, Zähringer U. J Biol Chem; 2013 May 31; 288(22):15654-67. PubMed ID: 23603911 [Abstract] [Full Text] [Related]
37. Comment on "Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus". von Aulock S, Hartung T, Hermann C. J Immunol; 2007 Mar 01; 178(5):2610; author reply 2610-1. PubMed ID: 17312096 [No Abstract] [Full Text] [Related]
38. Alexidine and chlorhexidine bind to lipopolysaccharide and lipoteichoic acid and prevent cell activation by antibiotics. Zorko M, Jerala R. J Antimicrob Chemother; 2008 Oct 01; 62(4):730-7. PubMed ID: 18635521 [Abstract] [Full Text] [Related]
39. Lipoprotein in the cell wall of Staphylococcus aureus is a major inducer of nitric oxide production in murine macrophages. Kim NJ, Ahn KB, Jeon JH, Yun CH, Finlay BB, Han SH. Mol Immunol; 2015 May 01; 65(1):17-24. PubMed ID: 25600878 [Abstract] [Full Text] [Related]
40. Presentation of lipoteichoic acid potentiates its inflammatory activity. Deininger S, Traub S, Aichele D, Rupp T, Baris T, Möller HM, Hartung T, von Aulock S. Immunobiology; 2008 May 01; 213(6):519-29. PubMed ID: 18514754 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]